Mochi Health vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Mochi Health beats Willow overall, scoring 7.7/10 vs 7.5/10. Mochi Health is more affordable at $178/mo vs $299/mo. Choose Mochi Health for users who want a tech-forward platform with app-based tracki. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side look at Mochi Health and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Mochi Health

#18 of 52

7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health

Willow

#24 of 52

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Mochi Health	Willow
Our Score	7.7/10	7.5/10
Starting Price	$178/mo	$299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want a tech-forward platform with app-based tracking	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#18	#24
Get started	Visit Mochi Health	Visit Willow

Pros & Cons Compared

Mochi Health

Pros

+Flat $99/mo semaglutide at ALL dose levels, saves $100-200/mo vs competitors who charge more at higher doses
+4 semaglutide formats: injection, oral tablet, oral drops, and microdose, the most delivery options of any platform
+Registered dietitians included alongside physicians, not just medication, but nutritional support
+Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

−Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
−No refunds for payments made over 30 days ago, limited consumer protection window
−Relatively new company (founded 2022) with less track record than established platforms

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Mochi Health edges out Willow with a score of 7.7/10 vs 7.5/10. If budget is your priority, Mochi Health starts at $178/mo compared to Willow's $299/mo. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Mochi Health nor Willow feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review